Future of biomarkers in assessment

The future application of biomarkers in critical illness will be to select and guide therapy. Selective biomarkers could analyze a pathophysiologic perturbation or noxious mediator to counteract or the need to replete a deficient protective protein. Functional genomics could identify patients at risk for illness or at risk for a poor outcome in critical illness. Genetic expression studies could help differentiate patients with the presence in tissues of harmful bacteria and their toxins from those with noninfectious inflammation and could also help to monitor illnesses over time. Expressional and functional proteomics could lead to the identification of new biomarkers and organ-specific therapies.

  • Future innovations.
  • Nano switches
  • Alternative biomarkers
  • Future of environmental biomarkers
  • Biomarkers in Environmental Assessment.
  • Lifestyle of organisms in response to the environmental change

Related Conference of Future of biomarkers in assessment

September 17-19, 2018

International Genome Editing & Engineering Conference

Venice, Italy

Future of biomarkers in assessment Conference Speakers

Recommended Sessions

Related Journals

Are you interested in